{"title":"Plasma Proteomic Landscape of Multidimensional Sleep Health and Its Association With Depression Risk Under Genetic Susceptibility","authors":"Feng Chen, Yanggang Hong, Yue Zhu, Yukai Wang, Qi Chen, Jiajun Li, Yangguang Lu, Haoxiong Guan, Huixiang Sheng, Ruijie Xie, Fan Ye","doi":"10.1155/da/9191032","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Background</h3>\n \n <p>Multidimensional sleep health, encompassing duration, snoring, chronotype, insomnia symptoms, and daytime sleepiness, is associated with various chronic diseases. However, its relationship with depression risk, especially the underlying molecular mechanisms across different levels of genetic susceptibility, remains unclear.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>In this prospective cohort study, we analyzed data from 36,852 UK Biobank participants, integrating multidimensional sleep scores, plasma proteomic data covering 2,911 proteins, and polygenic risk scores (PRS) for depression. Sleep-related proteins were identified via elastic net regression, and their associations with incident depression were assessed using Cox proportional hazards models. Mediation and interaction analyses were conducted to explore the role of proteomic features and their effect modification by genetic risk.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Seventy-three plasma proteins were selected by elastic net as sleep-related proteomic features, mainly involving immune regulation, neural signaling, metabolic homeostasis, and extracellular matrix remodeling. The proteomic score derived from these features was positively correlated with sleep health (<i>r</i> = 0.234, <i>p</i> < 1<i>×</i>10<sup>−100</sup>). Healthy sleepers had a lower risk of depression (HR = 0.553, 95% CI: 0.454–0.674, <i>p</i> < 0.001), as did those with higher proteomic scores (HR = 0.660, 95% CI: 0.566–0.770, <i>p</i> < 0.001). Mediation analysis suggested that the proteomic signature statistically accounted for a modest proportion of the observed association between sleep health and incident depression. A significant additive interaction was observed between unhealthy sleep and high genetic risk (RERI = 0.280, 95% CI: 0.022–0.538).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>This study characterizes the plasma proteomic profile of multidimensional sleep health and identifies sleep-associated proteomic signatures related to incident depression across levels of genetic susceptibility. These findings highlight potential biological pathways for further investigation and require independent replication and causal validation before clinical interpretation.</p>\n </section>\n </div>","PeriodicalId":55179,"journal":{"name":"Depression and Anxiety","volume":"2026 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/da/9191032","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Depression and Anxiety","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/da/9191032","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Multidimensional sleep health, encompassing duration, snoring, chronotype, insomnia symptoms, and daytime sleepiness, is associated with various chronic diseases. However, its relationship with depression risk, especially the underlying molecular mechanisms across different levels of genetic susceptibility, remains unclear.
Methods
In this prospective cohort study, we analyzed data from 36,852 UK Biobank participants, integrating multidimensional sleep scores, plasma proteomic data covering 2,911 proteins, and polygenic risk scores (PRS) for depression. Sleep-related proteins were identified via elastic net regression, and their associations with incident depression were assessed using Cox proportional hazards models. Mediation and interaction analyses were conducted to explore the role of proteomic features and their effect modification by genetic risk.
Results
Seventy-three plasma proteins were selected by elastic net as sleep-related proteomic features, mainly involving immune regulation, neural signaling, metabolic homeostasis, and extracellular matrix remodeling. The proteomic score derived from these features was positively correlated with sleep health (r = 0.234, p < 1×10−100). Healthy sleepers had a lower risk of depression (HR = 0.553, 95% CI: 0.454–0.674, p < 0.001), as did those with higher proteomic scores (HR = 0.660, 95% CI: 0.566–0.770, p < 0.001). Mediation analysis suggested that the proteomic signature statistically accounted for a modest proportion of the observed association between sleep health and incident depression. A significant additive interaction was observed between unhealthy sleep and high genetic risk (RERI = 0.280, 95% CI: 0.022–0.538).
Conclusion
This study characterizes the plasma proteomic profile of multidimensional sleep health and identifies sleep-associated proteomic signatures related to incident depression across levels of genetic susceptibility. These findings highlight potential biological pathways for further investigation and require independent replication and causal validation before clinical interpretation.
期刊介绍:
Depression and Anxiety is a scientific journal that focuses on the study of mood and anxiety disorders, as well as related phenomena in humans. The journal is dedicated to publishing high-quality research and review articles that contribute to the understanding and treatment of these conditions. The journal places a particular emphasis on articles that contribute to the clinical evaluation and care of individuals affected by mood and anxiety disorders. It prioritizes the publication of treatment-related research and review papers, as well as those that present novel findings that can directly impact clinical practice. The journal's goal is to advance the field by disseminating knowledge that can lead to better diagnosis, treatment, and management of these disorders, ultimately improving the quality of life for those who suffer from them.